If you are an individual living with diabetes, you've probably heard the terms ?MATRIX clinical research study? more frequently in the recent past. Researchers are becoming closer to finding a treatment for diabetic foot ulcers, an ailment that many with diabetes have to deal with on a daily basis. If you are looking into a clinical research study to find more information on wound healing, you may want to look into the current MATRIX clinical research study.

The study is evaluating whether an investigational medication called Excellarate, or GAM501, is a safe and effective way to treat diabetic foot ulcers. The topical gel is being applied once and twice to study patients over the course of the study. A placebo group is also taking part in the study, along with a group of individuals who are using a standardized wound treatment. The eligibility to participate in the study is based on a specific set of standards set by the FDA. Finding out if you qualify to participate is easy and this information is readably available online.

Questions that are asked include: Are you 18 years of age or older? Have you been diagnosed with diabetes (Type I or Type II)? Do you take insulin or other medication to control your blood sugars? Do you have a foot ulcer that has been present for six weeks or more? Are you willing to wear a special protective show for up to 26 weeks?

If you meet all of these criteria and still want to participate in the MATRIX clinical research study, you will be asked for your contact information and a clinical research study staff member will contact you to gather more information. Make sure to consult with your doctor to see if you are physically capable of taking part in this study.